Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

August 25, 2008
Bioniche Animal Health Immunotherapy Now Listed as “Organic” for Use in Cattle

August 18, 2008
Bioniche Phase III Clinical Trial in Bladder Cancer Progressing Well

Investors

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Shareholder Information

Inquiries related to stock transfer, lost certificates or address changes should be directed to our Transfer Agent, CIBC Mellon Trust Company.

Contact information:

CIBC Mellon Trust Company
P.O. Box 7010
Adelaide St. Postal Station
Toronto, Ontario M5C 2W9
Tel: (416) 643-5500
Toll free: (800) 387-08
25 Fax: (416) 643-5501
E-mail: inquiries@cibcmellon.com

Bioniche financial reports can be downloaded here

Request investor materials by regular mail here

All Bioniche publicly-listed documents can be viewed here

E-mail Alerts

To automatically receive an e-mail alert when Bioniche news releases are posted to this site, enter your e-mail address here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy